In pathway analysis and cancer immune correlation analysis, we observed that SRSFs were associated with the activation or inhibition of multiple immune pathways, and were also closely related to the expression of multiple immune checkpoints (LAG3, CD274, CTLA4, TIGIT, PDCD1). This evidence concerns the gene PDCD1 and cancer.